Integrated Core Strategies (Asia) Pte. Ltd. 13D and 13G filings for Puma Biotechnology, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2025-02-03 4:00 pm Sale | 2024-12-31 | 13G | Puma Biotechnology, Inc. PBYI | Integrated Core Strategies (Asia) Pte. Ltd. | 1,894,126 3.900% | -1,270,123 (-40.14%) | Filing |
| 2024-01-30 4:08 pm Purchase | 2023-12-31 | 13G | Puma Biotechnology, Inc. PBYI | Integrated Core Strategies (Asia) Pte. Ltd. | 3,164,249 6.700% | 487,336 (+18.21%) | Filing |
| 2023-01-19 4:19 pm Purchase | 2022-12-31 | 13G | Puma Biotechnology, Inc. PBYI | Integrated Core Strategies (Asia) Pte. Ltd. | 2,676,913 5.800% | 439,214 (+19.63%) | Filing |
| 2022-01-14 4:08 pm Purchase | 2022-01-06 | 13G | Puma Biotechnology, Inc. PBYI | Integrated Core Strategies (Asia) Pte. Ltd. | 2,237,699 5.500% | 2,237,699 (New Position) | Filing |